{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:07:23Z","timestamp":1771304843525,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00540-020-02847-y","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T07:34:46Z","timestamp":1599723286000},"page":"912-923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Open randomized trial of the effects of 6% hydroxyethyl starch 130\/0.4\/9 and 5% albumin on safety profile, volume efficacy, and glycocalyx degradation in hepatic and pancreatic surgery"],"prefix":"10.1007","volume":"34","author":[{"given":"Toshinari","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"2847_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/00000658-196111000-00005","volume":"154","author":"T Shires","year":"1961","unstructured":"Shires T, Williams J, Brown F. Acute change in extracellular fluid associated with major surgical procedures. Ann Surg. 1961;154:803\u201310.","journal-title":"Ann Surg"},{"key":"2847_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/TA.0b013e3182092abb","volume":"70","author":"B Schn\u00fcriger","year":"2011","unstructured":"Schn\u00fcriger B, Inaba K, Wu T, Eberle BM, Belzberg H, Demetriades D. Crystalloids after primary colon resection and anastomosis at initial trauma laparotomy: excessive volumes are associated with anastomotic leakage. J Trauma. 2011;70:603\u201310.","journal-title":"J Trauma"},{"key":"2847_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s00101-003-0557-0","volume":"52","author":"M Jacob","year":"2003","unstructured":"Jacob M, Rehm M, Orth V, L\u00f6tsch M, Brechtelsbauer H, Weninger E, Finsterer U. Exact measurement of the volume effect of 6% hydroxyethyl starch130\/0.4 (Voluven) during acute preoperative normovolemic hemodilution. Anaesthesist. 2003;52:896\u2013904.","journal-title":"Anaesthesist"},{"key":"2847_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/00000542-200003000-00008","volume":"92","author":"M Rehm","year":"2000","unstructured":"Rehm M, Orth V, Kreimeier U, Thiel M, Haller M, Brechtelsbauer H, Finsterer U. Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology. 2000;92:657\u201364.","journal-title":"Anesthesiology"},{"key":"2847_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1213\/01.ANE.0000159171.26521.31","volume":"101","author":"GP Joshi","year":"2005","unstructured":"Joshi GP. Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg. 2005;101:601\u20135.","journal-title":"Anesth Analg"},{"key":"2847_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1213\/ANE.0b013e31827175da","volume":"116","author":"P Van Der Linden","year":"2013","unstructured":"Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013;116:35\u201348.","journal-title":"Anesth Analg"},{"key":"2847_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","volume":"118","author":"C Martin","year":"2013","unstructured":"Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387\u201394.","journal-title":"Anesthesiology"},{"key":"2847_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1001\/jama.2013.280502","volume":"310","author":"D Annane","year":"2013","unstructured":"Annane D, Siami S, Jaber S, Martin C, Elatrous S, Decl\u00e8re AD, Preiser JC, Outin H, Troch\u00e9 G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Reignier J, Abroug F, Berger P, Clec'h C, Cousson J, Thibault L, Chevret S, CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA. 2013;310:1809\u201317.","journal-title":"JAMA"},{"key":"2847_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/ALN.0000000000001927","volume":"128","author":"T Kammerer","year":"2018","unstructured":"Kammerer T, Brettner F, Hilferink S, Hulde N, Klug F, Pagel JI, Karl A, Crispin A, Hofmann-Kiefer K, Conzen P, Rehm M. No differences in renal function between balanced 6% hydroxyethyl starch (130\/0.4) and 5% albumin for volume replacement therapy in patients undergoing cystectomy: a randomized controlled trial. Anesthesiology. 2018;128:67\u201378.","journal-title":"Anesthesiology"},{"key":"2847_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33:209\u201390.","journal-title":"Mol Aspects Med"},{"key":"2847_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/00000542-200606000-00018","volume":"104","author":"M Jacob","year":"2006","unstructured":"Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology. 2006;104:1223\u2013311.","journal-title":"Anesthesiology"},{"key":"2847_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/cvr\/cvq137","volume":"87","author":"BF Becker","year":"2010","unstructured":"Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits but great potential. Cardiovasc Res. 2010;87:300\u201310.","journal-title":"Cardiovasc Res"},{"key":"2847_CR13","first-page":"CD002042","volume":"10","author":"JL Carson","year":"2016","unstructured":"Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016;10:CD002042.","journal-title":"Cochrane Database Syst Rev"},{"key":"2847_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"2847_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12882-017-0750-z","volume":"18","author":"L Yessayan","year":"2017","unstructured":"Yessayan L, Neyra JA, Canepa-Escaro F, Vasquez-Rios G, Heung M, Yee J. Effect of hyperchloremia on acute kidney injury in critically ill septic patients: a retrospective cohort study. BMC Nephrol. 2017;18:346.","journal-title":"BMC Nephrol"},{"key":"2847_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13054-015-1065-8","volume":"19","author":"JY Kim","year":"2015","unstructured":"Kim JY, Joung KW, Kim KM, Kim MJ, Kim JB, Jung SH, Lee EH, Choi IC. Relationship between a perioperative intravenous fluid administration strategy and acute kidney injury following off-pump coronary artery bypass surgery: an observational study. Crit Care. 2015;19:350.","journal-title":"Crit Care"},{"key":"2847_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1213\/ANE.0000000000003741","volume":"127","author":"A Zarbock","year":"2018","unstructured":"Zarbock A, Koyner JL, Hoste EAJ, Kellum JA. Update on perioperative acute kidney injury. Anesth Analg. 2018;127:1236\u201345.","journal-title":"Anesth Analg"},{"key":"2847_CR18","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/ALN.0000000000000413","volume":"121","author":"ASP Kancir","year":"2014","unstructured":"Kancir ASP, Pleckaitiene L, Hansen TB, Ekel\u00f8f NP, Pedersen EB. Lack of nephrotoxicity by 6% hydroxyethyl starch 130\/0.4 during hip arthroplasty: a randomized controlled trial. Anesthesiology. 2014;121:948\u201358.","journal-title":"Anesthesiology"},{"key":"2847_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1213\/ANE.0000000000000596","volume":"120","author":"ASP Kancir","year":"2015","unstructured":"Kancir ASP, Johansen JK, Ekeloef NP, Pedersen EB. The effect of 6% hydroxyethyl starch 130\/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy. Anesth Analg. 2015;120:608\u201318.","journal-title":"Anesth Analg"},{"key":"2847_CR20","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1213\/ANE.0000000000002778","volume":"126","author":"JI Pagel","year":"2018","unstructured":"Pagel JI, Rehm M, Kammerer T, Hulde N, Speck E, Briegel J, Reinholz F, Crispin A, Hofmann-Kiefer KF. Hydroxyethyl starch 130\/.04 and its impact on perioperative outcome. Anesth Analg. 2018;126:1949\u201356.","journal-title":"Anesth Analg"},{"key":"2847_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/ALN.0000000000002501","volume":"130","author":"A Joosten","year":"2019","unstructured":"Joosten A, Delaporte A, Mortier J, Ickx B, Van Obbergh L, Vincent JL, Cannesson M, Rinehart J, Van der Linden P. Long-term impact of crystalloid versus colloid solutions on renal function and disability-free survival after major abdominal surgery. Anesthesiology. 2019;130:227\u201336.","journal-title":"Anesthesiology"},{"key":"2847_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/ALN.0000000000001936","volume":"128","author":"A Joosten","year":"2018","unstructured":"Joosten A, Delaporte A, Ickx B, Touihri K, Stany I, Barvais L, Obbergh LV, Loi P, Rinehart J, Cannesson M, Van der Linden P. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system: a randomized, double-blinded, controlled trial in major abdominal surgery. Anesthesiology. 2018;128:55\u201366.","journal-title":"Anesthesiology"},{"key":"2847_CR23","unstructured":"European Medicines Agency. Assessment report for solutions for infusion containing hydroxyethyl starch Procedure under Article 107i of Directive 2001\/83\/EC Procedure number: EMEA\/H\/A-107i\/1376.**"},{"key":"2847_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14994","author":"AE Duncan","year":"2020","unstructured":"Duncan AE, Jia Y, Soltesz E, Leung S, Yilmaz HO, Mao G, Timur AA, Kottke-Marchant K, Rogers HJ, Ma C, Ince I, Karimi N, Yagar S, Trombetta C, Sessler DI. Effect of 6% hydroxyethyl starch 130\/04 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial. Anaesthesia. 2020. https:\/\/doi.org\/10.1111\/anae.14994.","journal-title":"Anaesthesia"},{"key":"2847_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00595-018-1752-6","volume":"49","author":"T Fujita","year":"2019","unstructured":"Fujita T, Okada N, Horikiri Y, Sato T, Fujiwara H, Mayanagi S, Kanamori J, Yamamoto H, Daiko H. Safety and efficacy of hydroxyethyl starch 6% 130\/0.4\/9 solution versus 5% human serum albumin in thoracic esophagectomy with 3-field lymph nodes dissection. Surg Today. 2019;49:427\u201334.","journal-title":"Surg Today"},{"key":"2847_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.accpm.2019.08.002","volume":"39","author":"S Degoul","year":"2020","unstructured":"Degoul S, Chazard E, Lamer A, Lebuffe G, Duhamel A, Tavernier B. Intraoperative administration of 6% hydroxyethyl starch 130\/0.4 is not associated with acute kidney injury in elective non-cardiac surgery: a sequential and propensity-matched analysis. Anaesth Crit Care Pain Med. 2020;39:199\u2013206.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"2847_CR27","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004592","author":"H Miyao","year":"2019","unstructured":"Miyao H, Kotake Y. Renal morbidity of 6% hydroxyethyl starch130\/04 in 9000 propensity score matched pairs of surgical patients. Anesth Analg. 2019. https:\/\/doi.org\/10.1213\/ANE.0000000000004592.","journal-title":"Anesth Analg"},{"key":"2847_CR28","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1213\/ANE.0000000000003796","volume":"127","author":"R Weiss","year":"2018","unstructured":"Weiss R, Wenk M, Van Aken H, Zwissler B, Chappell D, Zarbock A. HES or how to end science. Anesth Analg. 2018;127:1440\u20134.","journal-title":"Anesth Analg"},{"key":"2847_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s001340050833","volume":"25","author":"J Treib","year":"1999","unstructured":"Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med. 1999;25:258\u201368.","journal-title":"Intensive Care Med"},{"key":"2847_CR30","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1399-6576.2006.01138.x","volume":"50","author":"G Chen","year":"2006","unstructured":"Chen G, Yan M, Lu QH, Gong M. Effects of two different hydroxyethyl starch solutions (HES200\/0.5 vs. HES130\/0.4) on the expression of platelet membrane glycoprotein. Acta Anaesthesiol Scand. 2006;50:1089\u201394.","journal-title":"Acta Anaesthesiol Scand"},{"key":"2847_CR31","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/00000539-200106000-00008","volume":"92","author":"A Franz","year":"2001","unstructured":"Franz A, Braunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg. 2001;92:1402\u20137.","journal-title":"Anesth Analg"},{"key":"2847_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/aas.12418","volume":"59","author":"S Yini","year":"2015","unstructured":"Yini S, Heng Z, Xin A, Xiaochun M. Effect of unfractionated heparin on endothelial glycolcalyx in a septic shock model. Acta Anaesthesiol Scand. 2015;59:160\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"key":"2847_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/SHK.0b013e31826f2583","volume":"38","author":"MS Strunden","year":"2012","unstructured":"Strunden MS, Bornscheuer A, Schuster A, Kiefmann R, Goetz AE, Heckel K. Glycocalyx degradation causes microvascular perfusion failure in the ex vivo perfused mouse lung: hydroxyethyl starch 130\/0.4 pretreatment attenuates this response. Shock. 2012;38:559\u201366.","journal-title":"Shock"},{"key":"2847_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/anae.13642","volume":"72","author":"TK Kim","year":"2017","unstructured":"Kim TK, Nam K, Cho YJ, Min JJ, Hong YJ, Park KU, Hong DM, Jeon Y. Microvascular reactivity and endothelial glycocalyx degradation when administering hydroxyethyl starch or crystalloid during off-pump coronary artery bypass graft surgery: a randomized trial. Anaesthesia. 2017;72:204\u201313.","journal-title":"Anaesthesia"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-020-02847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00540-020-02847-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-020-02847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T23:40:13Z","timestamp":1631058013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00540-020-02847-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2847"],"URL":"https:\/\/doi.org\/10.1007\/s00540-020-02847-y","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"assertion":[{"value":"14 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was registered prior to patient enrollment in the University hospital Medical Information Network (UMIN) clinical trials registry by number UMIN00001347. Principal investigator: Kaoru Koyama. Data for registration: April 1, 2014. Saitama Medical Center, Saitama Medical University Institutional Review Board (Clinical Trial Number 952). Principal investigator: Toshinari Suzuki. Data for registration: May 2, 2014.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration of clinical trials"}}]}}